Search Results - "Van Asten, K"

Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study by Brouckaert, O., Van Asten, K., Laenen, A., Soubry, A., Smeets, A., Nevelstreen, I., Vergote, I., Wildiers, H., Paridaens, R., Van Limbergen, E., Weltens, C., Moerman, P., Floris, G., Neven, P.

“…Purpose Evidence suggests that premenopausal obesity decreases and postmenopausal obesity increases breast cancer risk. Because it is not well known whether…”
Get full text

Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients by Lintermans, A, Van Asten, K, Jongen, L, Van Brussel, T, Laenen, A, Verhaeghe, J, Vanderschueren, D, Lambrechts, D, Neven, P

“…Abstract Background Aromatase inhibitor (AI) therapy is associated with musculoskeletal (MS) toxicity, which adversely affects quality of life and therapy…”
Get full text

A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI by Lintermans, A., Van Asten, K., Wildiers, H., Laenen, A., Paridaens, R., Weltens, C., Verhaeghe, J., Vanderschueren, D., Smeets, A., Van Limbergen, E., Leunen, K., Christiaens, M. R., Neven, P.

“…Aromatase inhibitor (AI) therapy for estrogen receptor-positive breast cancer is known to induce or enhance musculoskeletal problems. We have previously…”
Get full text

Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer by Neven, P., Jongen, L., Van Asten, K., Berteloot, P., Floris, G., Wildiers, H.

“…In this case-report we established a discordance of luminal subtype between core needle biopsy results at breast cancer diagnosis and surgical specimen results…”
Get full text

The fragile X mental retardation protein (FMRP) expression is associated with better distant metastasis free survival in a cohort of luminal-B like early breast cancers with long follow-up by Floris, G., Piedini, G., Laenen, A., Van Asten, K., Achsel, T., Brouckaert, O., Wildiers, H., Bagni, C., Neven, P.

Get full text

483 (PB-116) - The fragile X mental retardation protein (FMRP) expression is associated with better distant metastasis free survival in a cohort of luminal-B like early breast cancers with long follow-up by Floris, G., Piedini, G., Laenen, A., Van Asten, K., Achsel, T., Brouckaert, O., Wildiers, H., Bagni, C., Neven, P.

Get full text

Abstract P5-08-31: Withdrawal of exogenous hormones affects prognostic multigene signature results in early luminal breast cancer by Jongen, L, De Vries, P, Van Asten, K, Lintermans, A, Laenen, A, Wildiers, H, Floris, G, Neven, P

“…Background Early breast cancer (BC) outcomes are mainly estimated based on clinicopathological parameters and rarely include proliferation markers: (Ki-67),…”
Get full text

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients: an international multicentre hospital-based retrospective cohort study by Lambertini, M., Pinto, A.C., Ameye, L., Jongen, L., Del Mastro, L., Puglisi, F., Poggio, F., Bonotto, M., Floris, G., van Asten, K., Wildiers, H., Neven, P., de Azambuja, E., Paesmans, M., Azim, H.A.

Get full text

An international multicentre hospital-based retrospective cohort study evaluating the prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients by Lambertini, M., Pinto, A.C., Ameye, L., Jongen, L., Del Mastro, L., Puglisi, F., Bonotto, M., Poggio, F., Floris, G., van Asten, K., Wildiers, H., Neven, P., de Azambuja, E., Paesmans, M., Azim, H.A.

Get full text

29PA NEGATIVE PROGESTERONE RECEPTOR IN LUMINAL HER-2 NEGATIVE BREAST CANCER BY AGE AT DIAGNOSIS: 10 YEARS FOLLOW-UP by Olbrecht, S., Van Asten, K., Laenen, A., Remmerie, C., Wildiers, H., Floris, G., Christiaens, M.R., Vergote, I., Neven, P.

Get full text

Abstract P6-09-12: Breast cancer characteristics and the levonorgestrel intrauterine device. A monocentric retrospective study by Borowski, E, Poppe, A, Laenen, A, Remmerie, C, Van Asten, K, Nevelsteen, I, Smeets, A, Weltens, C, Peeters, S, Leunen, K, Berteloot, P, Amant, F, Vergote, I, Van Limbergen, E, Christiaens, M-R, Wildiers, H, Floris, G, Poppe, W, Neven, P

“…OBJECTIVE: The levonorgestrel-intrauterine device (LNG-IUD) is a widely used contraceptive method. It is not clear if LNG-IUD users are more likely to develop…”
Get full text

Abstract P1-13-09: Sensitive liquid chromatography-tandem mass spectrometry method for serum estradiol and estrone assessment without derivatisation, overcoming cross reactivity with exemestane by Lintermans, A, Pauwels, S, Vermeersch, P, Jans, I, Billen, J, Van Asten, K, Vanderschueren, D, Neven, P

“…Objective Measuring serum estrogen levels in postmenopausal women on oral aromatase inhibitors is important but challenging. Direct immunoassays are the most…”
Get full text

A Negative Progesterone Receptor in Luminal Her-2 Negative Breast Cancer by Age at Diagnosis: 10 Years Follow-Up by Olbrecht, S., Van Asten, K., Laenen, A., Remmerie, C., Wildiers, H., Floris, G., Christiaens, M.R., Vergote, I., Neven, P.

Get full text

Abstract P1-13-08: Arthralgia and changes in serum levels of IGF-I, its binding protein and estrogen in breast cancer patients on endocrine agents by Lintermans, A, Van Asten, K, Wildiers, H, Paridaens, R, Leunen, K, Smeets, A, Amant, F, Christiaens, M-R, Verhaeghe, J, Vermeersch, P, Vanderschueren, D, Neven, P

“…Objective Aromatase inhibitors (AIs) frequently induce or enhance musculoskeletal problems, also known as the AI-induced musculoskeletal syndrome (AIMSS)…”
Get full text

Influence of body mass Index on breast cancer features by Van Asten, K, Dieudonne, A, Lintermans, A, Wildiers, H, Floris, G, Laenen, A, Janssen, H, Smeets, A, Christiaens, M, Neven, P

“…A high body mass index (BMI) affects morbidity and mortality. Obesity (BMI >30 kg/m[sup 2]) is an independent prognostic factor for breast cancer (BC) related…”
Get full text

Prospective assessment of loss of grip strength by baseline BMI in breast cancer patients receiving adjuvant aromatase inhibitors or tamoxifen by Lintermans, A, Van Asten, K, Wildiers, H, Paridaens, R, Weltens, C, Van Limbergen, E, Smeets, A, Leunen, K, Christiaens, M R, Neven, P

“…Aromatase inhibitors (Als) induce or enhance musculoskeletal problems. Underlying mechanisms are probably multiple, but remain unknown. We have previously…”
Get full text

Abstract OT3-2-04: Prospective multicenter study evaluating the effect of impaired tamoxifen metabolization on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting - The CYPTAM-BRUT 2 trial by Van Asten, K, Dieudonné, A-S, Lintermans, A, Blomme, C, Brouckaert, O, Lambrechts, D, Wildiers, H, Christiaens, M-R, Timmerman, D, Van Calster, B, Decloedt, J, Berteloot, P, Verhoeven, D, Joerger, M, Zaman, K, Dezentjé, V, Neven, P

“…Background Tamoxifen is often used for the prevention and treatment of hormone receptor positive breast cancer. It is a prodrug which is metabolized by human…”
Get full text

P270 Outcome of HER2 positive breast cancer by PR expression since the introduction of trastuzumab by Asten, K. Van, Jongen, L, Beuselinck, B, Laenen, A, Wildiers, H, Poppe, A, Floris, G, Christiaens, M, Neven, P

Get full text

Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancer by Neven, P, Jongen, L, Van Asten, K, Berteloot, P, Floris, G, Wildiers, H

Get full text

Independence within reach. Ergotherapy treatment of children with a congenital reduction defect by van Asten, K, Verhoef, J A

“…The occupational therapy department of the University Hospital of Leiden treats a relatively large number of children, born with a dysmelia of the forearm…”
Get more information